Users Discontinuing Anti-Obesity Medications Gain Back Pounds Far More Rapidly Compared to Dieters

New research suggests that individuals who stop using blockbuster slimming jabs like Mounjaro or Wegovy tend to recover reduced body mass much more quickly than those who halt conventional diet and exercise plans.

Findings released in a major medical journal shows that while overweight individuals can lose a large proportion of their body weight while undergoing treatment, the weight comes back at an estimated rate of nearly a kilo each month once they quit.

"Individuals using such medications should be aware of the danger of fast weight regain when the medication concludes," stated researcher Dr. Susan Jebb.

That rate of regain means a return to starting mass in about 18 months.

Comparing Treatments

The study, which reviewed dozens of trials involving over 9,000 of participants, compared the effects of GLP-1 agonists with conventional dieting.

Researchers note that people who lose weight through diet and exercise typically have a slower weight regain—perhaps 100 grams monthly—post-intervention.

Explaining the Rapid Regain

Nutrition scientists believe the way of the drugs explains the amplified rebound.

The injections copy a body's own chemical called glucagon-like peptide-1, which moderates appetite.

"Sustained high doses of the hormone levels several times higher than normal might result in the system to produce less of its own natural GLP-1, and could diminish sensitivity to its effects," noted Dr. Adam Collins, a nutrition expert.

"Discontinuation of this hormone supplement leads to hunger is uncontrolled, making overeating much more probable."

A Chronic Disease?

The NHS suggest the jabs for individuals with weight-linked medical conditions, alongside prescribed lifestyle changes.

Many experts say that, due to the high risk of relapse, the treatment might need to be long-term.

This perspective is reinforced by pharmaceutical companies, who say that the findings "underscore the long-term character of obesity," comparing it to managing diseases like hypertension.

Patient Accounts

Individuals who have stopped the medication report a intense return of hunger.

"I experienced a switch flipping and you're instantly starving," described an individual.

This challenge is exacerbated if users have not developed lasting dietary or behavioural changes during therapy.

Growing Adoption

Figures indicate that millions of adults in the UK have used these injections in the past year, with demand being substantial.

• Adoption is higher among females compared to men.
• The 40s and 50s age group shows the greatest usage rates.
• A large proportion access the drugs through private prescriptions rather than public health services.

Ultimately, experts emphasize that while these medications are effective agents for weight loss, they are not a magic fix and long-term success hinges on ongoing behavioural management.